Number of the records: 1
trazodón
SYS d014196 LBL 00000nz--a2200000o--4500 005 20250606214334.6 008 921119|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D03.383.606.900 065 $a D03.383.725.791.900 066 $a 01 $c 03 150 $a trazodón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d014151 $Y Anti-Anxiety Agents $w P $a anxiolytiká 550 $7 sllk_us_auth*d017367 $Y Selective Serotonin Reuptake Inhibitors $w P $a inhibítory spätného vychytávania serotonínu, selektívne 550 $7 sllk_us_auth*d018687 $Y Antidepressive Agents, Second-Generation $w P $a antidepresíva II. generácie 665 $a 86(75); was see under PIPERAZINES 1975-85 $2 eng 665 $a Piperazines (1971-1974) $2 eng 665 $a Pyridines (1971-1974) $2 eng 665 $a Triazoles (1971-1974) $2 eng 680 9-
$i A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) $2 eng 750 -2
$a Trazodone $2 eng 980 $x M
Number of the records: 1